2019-2024年北京市某三甲医院艾滋病住院患者费用及其影响因素

Costs of hospitalized patients with AIDS in a three-A hospital of Beijing from 2019 to 2024 and influencing factors

  • 摘要: 目的 分析艾滋病住院患者费用构成变动趋势及影响因素。方法 采用回顾性研究方法,分析首都医科大学附属北京地坛医院2019-2024年771例艾滋病住院患者例均住院费用及其构成变化,并运用单因素分析与多重线性回归模型探讨住院费用的影响因素。结果 艾滋病住院患者例均住院总费用呈下降趋势,由2020年的27 044.03元降至2024年的9 329.80元。费用结构持续优化,药费构成比下降7.94%,耗材费构成比下降2.04%,诊断治疗费始终为核心构成。结构变动度分析显示,诊断治疗费与药费构成比年度波动显著,血液及血制品费、耗材费构成比持续走低(均P<0.05)。多重线性回归分析显示,住院天数(β=0.383)、其他诊断个数(≥6个:β=0.585)、来源地区(外埠:β=0.306)、医保类型(居民医保:β=0.115)及是否手术(β=0.054)是住院费用的影响因素(均P<0.05)。结论 医院艾滋病患者住院费用控制成效显著,住院天数与其他诊断数量是影响费用的关键临床因素,并应关注外埠及居民医保患者的经济负担。

     

    Abstract: OBJECTIVE To analyze the changing trend of structure of hospitalization costs of the AIDS patients and observe the influencing factors. METHODS By means of retrospective study, the changes of hospitalization costs per case and their compositions of 771 AIDS patients who were hospitalized in Beijing Ditan Hospital Affiliated to Capital Medical University from 2019 to 2024 were analyzed. Univariate analysis and multiple linear regression analysis were performed to explore the influencing factors for the hospitalization costs. RESULTS The total hospitalization cost per case of the hospitalized patients with AIDS showed a downward trend, decreasing from 27 044.03 yuan in 2020 to 9 329.80 yuan in 2024. The structure of the cost has been continuously optimized, with the proportion of pharmaceutical expenses decreasing by 7.94%, the proportion of consumable expenses decreasing by 2.04%, while the cost of diagnosis and treatment remained the core component. The analysis of structural variation indicated that the proportions of diagnosis and treatment fees as well as pharmaceutical expenses fluctuated significantly, while the proportions of blood and blood products expenses as well as consumables expenses continuously decreased (all P<0.05). Multiple linear regression analysis showed that the length of hospital stay(β=0.383), number of additional diagnoses (no less than 6: β=0.585), patient origin (out-of-town: β=0.306), type of medical insurance (resident-based medical insurance: β=0.115), and surgical status (β=0.054) were the influencing factors for the hospitalization costs(all P<0.05). CONCLUSIONS The hospitalization costs of the hospitalized patients with AIDS have been remarkably controlled in the hospital. The length of hospital stay and number of additional diagnoses are the major clinical factors affecting the costs. It is necessary to pay close attention to the economic burden of the out-of-town patients and the resident-based medical insurance patients.

     

/

返回文章
返回